These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glycogen storage disease: recommendations for treatment. Fernandes J; Leonard JV; Moses SW; Odièvre M; di Rocco M; Schaub J; Smit GP; Ullrich K; Durand P Eur J Pediatr; 1988 Apr; 147(3):226-8. PubMed ID: 3292244 [TBL] [Abstract][Full Text] [Related]
4. Diet and growth of children with glycogen storage disease Types I and III. Daeschel IE; Janick LS; Kramish MJ; Coleman RA J Am Diet Assoc; 1983 Aug; 83(2):135-41. PubMed ID: 6409953 [TBL] [Abstract][Full Text] [Related]
6. Cornstarch therapy in a patient with type III glycogen storage disease. Borowitz SM; Greene HL J Pediatr Gastroenterol Nutr; 1987; 6(4):631-4. PubMed ID: 3480949 [TBL] [Abstract][Full Text] [Related]
7. The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada. Roscher A; Patel J; Hewson S; Nagy L; Feigenbaum A; Kronick J; Raiman J; Schulze A; Siriwardena K; Mercimek-Mahmutoglu S Mol Genet Metab; 2014 Nov; 113(3):171-6. PubMed ID: 25266922 [TBL] [Abstract][Full Text] [Related]
8. Hepatic glycogen storage disorders: what have we learned in recent years? Burda P; Hochuli M Curr Opin Clin Nutr Metab Care; 2015 Jul; 18(4):415-21. PubMed ID: 26001652 [TBL] [Abstract][Full Text] [Related]
9. The Phenotypic and Genetic Spectrum of Glycogen Storage Disease Type VI. Grünert SC; Hannibal L; Spiekerkoetter U Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440378 [TBL] [Abstract][Full Text] [Related]
10. Diagnosing and managing type I and type III glycogen storage diseases. Mahoney KG MCN Am J Matern Child Nurs; 1984; 9(5):338-42. PubMed ID: 6433137 [No Abstract] [Full Text] [Related]
11. Hepatic ultrasound findings in the glycogen storage diseases. Lee P; Mather S; Owens C; Leonard J; Dicks-Mireaux C Br J Radiol; 1994 Nov; 67(803):1062-6. PubMed ID: 7820397 [TBL] [Abstract][Full Text] [Related]
12. Glycogen storage disease type I and III and pyruvate carboxylase deficiency: results of long-term treatment with uncooked cornstarch. Ullrich K; Schmidt H; van Teeffelen-Heithoff A Acta Paediatr Scand; 1988 Jul; 77(4):531-6. PubMed ID: 3134793 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of cornstarch therapy in type III glycogen-storage disease. Gremse DA; Bucuvalas JC; Balistreri WF Am J Clin Nutr; 1990 Oct; 52(4):671-4. PubMed ID: 2403059 [TBL] [Abstract][Full Text] [Related]
16. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease. Wolfsdorf JI; Crigler JF J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):136-43. PubMed ID: 10435649 [TBL] [Abstract][Full Text] [Related]
17. Reversal of debrancher deficiency myopathy by the use of high-protein nutrition. Slonim AE; Weisberg C; Benke P; Evans OB; Burr IM Ann Neurol; 1982 Apr; 11(4):420-2. PubMed ID: 7049057 [TBL] [Abstract][Full Text] [Related]